A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...
Palantir Technology's (NASDAQ: PLTR) stock has been nearly unstoppable over the past year. Although Palantir attained a $236 ...
Many high-growth stocks rallied over the past year in expectation of lower interest rates, boosting their stock prices and ...
When top growth stocks drop as these have, there are almost always legitimate problems. Despite the tangible reasons for ...